CD40 and neoplasm: CD40 is expressed on the surface of B cells, monocytes, macrophages and dendritic cells (DCs) and plays a key role in bridging innate and adaptive immunity by “licensing” DCs to prime and activate T cells, thereby triggering tumor-specific T cell immunity.